Abstract:Background: Currently, the most widely used treatment for diabetes is the daily subcutaneous injection of recombinant human insulin. Daily injections, however, cannot match the physio- logical biphasic behavior of normal insulin release, nor can they precisely meet the demands of food intake, exercise, and stress. Cellular encapsulation, or immunoisolation, is a possible solu- tion to this problem. This cell-based therapy allows patients to receive the benefits of more phys- iological insulin and blood glucose regulation, without the need for immunosuppressants that are associated with organ or cell transplantation. Methods: Immunoisolation capsules were fabricated out of aluminum and aluminum oxide using a two-step anodization procedure. The diffusion behavior of glucose, immunoglobulin G (IgG), and insulin were measured. Furthermore, the functionality and viability of encapsulated MIN6 cells were tested. Finally, live cells were stained and imaged using confocal microscopy. Results: Data indicated that this device is effective in allowing the transport of relevant mol- ecules such as glucose and insulin, while at the same time significantly impeding the transport of IgG, suggesting that it would be efficacious in protecting cell grafts in vivo. Furthermore, en- capsulated cells were able to respond dynamically to glucose input signals. Finally, cell staining showed that the viability of encapsulated cells is maintained after 24 h, although the cells ap- pear to be more heavily concentrated at the area that is closest to the membrane. Conclusions: This study has shown that nanoporous alumina membranes, with well-con- trolled pore sizes, can be used for the encapsulation of therapeutic cells and may provide an al- ternative encapsulation strategy for the treatment of diabetes.

Transglutaminase-Catalyzed Encapsulation of Individual Mammalian Cells with Biocompatible and Cytoprotective Gelatin Nanoshells.

Mild Formation of Core–shell Hydrogel Microcapsules for Cell Encapsulation

Conformal encapsulation of mammalian stem cells using modified hyaluronic acid

Encapsulation of Cells in a Collagen Matrix Surrounded by an Alginate Hydrogel Shell for 3D Cell Culture

Single‐Cell Nanoencapsulation: From Passive to Active Shells

A Novel Step-T-Junction Microchannel for the Cell Encapsulation in Monodisperse Alginate-Gelatin Microspheres of Varying Mechanical Properties at High Throughput

The Cell‐Isolation Capsules with Rod‐Like Channels Ensure the Survival and Response of Cancer Cells to Their Microenvironment

Immune‐Modulating Mucin Hydrogel Microdroplets for the Encapsulation of Cell and Microtissue

Single Cell Coating with Surface-Anchored Nanogel Improves the Engraftment and Reparative Potency of Transplanted Mesenchymal Stem Cells in Infarcted Rat Hearts

Cell encapsulation via microtechnologies

Encapsulation of Multiple Microalgal Cells via a Combination of Biomimetic Mineralization and LbL Coating

Progress technology in microencapsulation methods for cell therapy

Injectable and Tunable Gelatin Hydrogels Enhance Stem Cell Retention and Improve Cutaneous Wound Healing

Silicone cryogel skeletons enhance the survival and mechanical integrity of hydrogel-encapsulated cell therapies

Yolk-Shell Encapsulation of Cells by Biomimetic Mineralization and Visible Light-Induced Surface Graft Polymerization

Characterization of encapsulated cells within hyaluronic acid and alginate microcapsules produced via horseradish peroxidase-catalyzed crosslinking

Directing Encapsulation of Single Cells with DNA Framework Nucleator‐Based Hydrogel Growth

Developing Robust, Hydrogel-Based, Nanofiber-Enabled Encapsulation Devices (needs) for Cell Therapies.

Activation Transcription Factor 1 Involvement in the Regulation of Murine H-2D d Expression*

Microencapsulation of Normal and Transfected L929 Fibroblasts in a HEMA-MMA Copolymer

Nanoporous alumina capsules for cellular macroencapsulation: transport and biocompatibility.